This is the authors' abstract. We don't add key points for this paper.
Quality by Design (QbD) is an approach to assay development to determine the design space, which is the range of assay variable settings that should result in satisfactory assay quality. Typically, QbD is applied in manufacturing, but it works just as well in the preclinical space. Through three examples, we illustrate the QbD approach with experimental design and associated data analysis to determine the design space for preclinical assays.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jones et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: